ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/21/2025
Back to search
Official data from USPTO
ANDELYN BIOSCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
05/22/2025
Trademark type
Combined
Nice classes
5, 40, 42
Filing date
03/01/2022
Registration date
06/20/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/20/2023
Last transaction
05/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
08/12/2020
First use in commerce
10/25/2021
Drawing code
3
Owner type
03
Owner location
Columbus, OH
Examiner
RITTNER, HANNO
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word ANDELYN in a stylized font with the word BIOSCIENCES appearing beneath it, and a honeycomb pattern appearing to the right side of the words.
Holders and representatives
Holders
Andelyn Biosciences, Inc.
Representatives
Ajay A. Jagtiani Miles & Stockbridge P.C.
Technical classification
Nice Classes
Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsbiological preparationsgene therapy products for medical or pharmaceutical purposesgene therapiesviral vectorsDNA plasmidsnucleic-acid delivery products for use in the treatment of genetic diseases and disorders
Class 40
Manufacturing services for others in the field of pharmaceuticalsbiopharmaceuticalshealth care products and medical products; treatment of materialspharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticalscells and gene therapy reagents
Class 42
Product development for others relating to pharmaceuticalsbiopharmaceuticalshealth care products and medical products; scientific and technological consulting services in the pharmaceutical industryresearch and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticalsbiopharmaceuticalshealth care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research servicesproviding analytical testingbiosafety testingreporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays
Publications
History of USPTO decisions and trademark events.
23 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/08/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/08/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/08/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/08/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/08/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/20/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/20/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/04/2023
PUBO
PUBLISHED FOR OPPOSITION
04/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/28/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
02/28/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/28/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
02/28/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/28/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/20/2022
GNRT
NON-FINAL ACTION E-MAILED
12/20/2022
CNRT
NON-FINAL ACTION WRITTEN
12/20/2022
DOCK
ASSIGNED TO EXAMINER
12/13/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/05/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/04/2022
NWAP
NEW APPLICATION ENTERED
03/04/2022
Continuous trademark protection
Get notified about every new filing that threatens ANDELYN BIOSCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.